Shaman Botanicals
This article was originally published in The Tan Sheet
Executive Summary
Loren Israelsen named interim CEO at the new company. President of the consulting firm LDI Group, Israelsen will engage in early financing activities, negotiating partnering agreements and recruiting a full-time management team. Thomas Carlson, MD, senior director of ethnobiomedical field research at parent Shaman Pharmaceuticals, joins the interim team as acting VP of medical ethnobotany